Comments
Commented by Fabian Lorenz on March 29th, 2023 | 07:50 CEST
Nel ASA and Varta continue to decline: dynaCERT convinces analysts during an on-site visit
Being active in a market of the future is no guarantee for success. Shareholders of Varta had to painfully realize this in recent months. The German battery group has indeed reached an agreement with banks on restructuring. However, there can be no talk of a liberating blow. According to analysts, the share could continue to slide. Experts are also somewhat cautious about Nel ASA. The hydrogen specialist's chart does not look rosy either. In contrast, dynaCERT could be due for a revaluation in the current year. Experts believe the Greentech company has set the course for a commercial breakthrough in 2023.
Read
Commented by Stefan Feulner on March 28th, 2023 | 15:47 CEST
Critical metals existential - Plug Power, Almonty Industries, Nordex
The electric car market is poised for further exponential growth in the current decade. Supplier Bosch predicts that by 2030, two-thirds of all newly registered cars in Europe will be electric. As demand for e-vehicles grows, so does the need for the materials to make batteries. In addition to lithium, the critical metal tungsten is playing an increasingly important role due to its high density and high melting point. Up to now, production has taken place almost exclusively in China. However, a Canadian company that could become a supplier to the western world in the future is causing quite a stir.
Read
Commented by André Will-Laudien on March 28th, 2023 | 14:40 CEST
Switch now: Volkswagen, Meta Materials, Varta - Get out of banking and invest in climate change!
The banks are sputtering again. The somewhat more mature investors can well remember the horror year 2008 when the spectacular collapse of the small investment bank Bear Stearns occurred in the first half of the year. In May 2008, JPMorgan Chase had to take over the ailing institution in a night and fog operation. But that was just a preliminary flurry of activity. Lehman Brothers finally delivered the huge bankruptcy on September 15, 2008. That was the financial crisis's historical beginning, which only ended 7 years later. Now they are back, the troubled banks and the emergency takeover of Credit Suisse by UBS. What is next? That is the big question! After Corona and the Ukraine war, a recession combined with a banking crisis could be heading our way.
Read
Commented by Nico Popp on March 28th, 2023 | 07:36 CEST
E-cars - Out of a dream! BYD, BMW, First Phosphate
While German politicians are still discussing the end of the internal combustion engine, major car companies have long since made up their minds. The future is electric. But the mobility revolution is far from being a done deal! We explain where there are still pitfalls and why a small company from Canada could soon be sitting at the big levers to make the dream of clean e-mobility come true for everyone.
Read
Commented by Stefan Feulner on March 27th, 2023 | 09:31 CEST
American Lithium, Blackrock Silver and Standard Lithium - Lithium is increasingly scarce
Lithium-ion batteries are the most common battery technology for electronic devices, electric vehicles and energy storage due to their high energy density and long life. In addition, the critical metal is used in the aerospace industry, medical technology and metal processing. Demand is rising dramatically, while supply can hardly keep up, mainly due to the mobility shift. Producers of the scarce commodity will undoubtedly emerge as the beneficiaries of this overhang in the future.
Read
Commented by Armin Schulz on March 27th, 2023 | 09:28 CEST
Barrick Gold, Globex Mining, Deutsche Bank - Banking crises fuel investments in gold
In recent weeks, two major banks, Silicon Valley Bank and Credit Suisse, have caught the attention of investors as both institutions struggle with various problems. These developments have rekindled fears of a possible banking crisis, prompting investors to seek safe havens. One of the winners of this development has been the price of gold, which has surged in recent days. So today, we look at two precious metals companies and Deutsche Bank.
Read
Commented by Nico Popp on March 27th, 2023 | 09:26 CEST
Cost pressure in the healthcare system - how you benefit: Bayer, BioNxt, BioNTech
What do you think of the German healthcare system? While doctors regularly grumble about bureaucracy and patients about long waiting times or other inconsistencies, a new divide is opening up between pharmaceutical companies. Research-based pharmaceutical companies favour long patent protection, while generics manufacturers want more lax rules. We explain the system and highlight opportunities for investors.
Read
Commented by Juliane Zielonka on March 24th, 2023 | 07:55 CET
First Phosphate, Volkswagen and Vonovia - Winners in climate poker
On March 26, the residents of Berlin will vote on whether their city should become climate neutral by 2030 - 3.6 million inhabitants travel daily by car, bus and train. For mineral explorer companies like First Phosphate, the potential acceleration in demand is already a win-win, as demand for basic materials for batteries increases dramatically. Volkswagen, for example, may soon launch large-scale industrial production of cathode materials (CAM) and precursor materials (PCAM) in Europe, thanks to the go-ahead from regulators. Vonovia is also getting enterprising: the group owns 136,000 apartments in Berlin.
Read
Commented by Juliane Zielonka on March 23rd, 2023 | 08:02 CET
BioNxt Solutions, Bayer, BioNTech - These pharma stocks offer growth potential
The risk of cancer is increasing worldwide for people over the age of 50. The reasons for this are lack of sleep and exercise, pre-existing diseases and poor nutrition. It has now also been scientifically proven that permanent stress is a cause of Parkinson's disease. According to the WHO, disabilities and deaths due to Parkinson's are increasing faster worldwide than for any other neurological disease. Pharmaceutical and biotech companies are doing everything they can to improve the quality of life of those affected. The Canadian biotech company BioNxt is working on a comparative study to improve a therapy patch for treating Parkinson's and make accompanying drug products scalable. Bayer subsidiary Bluerock Therapeutics is using data from the Apple Watch to research Parkinson's symptoms. And CEO Uğur Şahin of BioNTech has closed a billion-dollar deal in cancer therapy.
Read
Commented by Fabian Lorenz on March 23rd, 2023 | 08:00 CET
Gold to USD 3,000? Barrick Gold and Desert Gold profit. What is going on at Vonovia?
Will the price of gold rise to USD 3,000 per ounce before the end of the year? That is what investment professional Leigh Goehring thinks is possible. He is a managing director at Goehring & Rozencwajg, manages a commodity fund, among other things, and expects a "decade of inflation." If the forecast comes true, gold stocks will at least be an attractive portfolio addition. In addition to industry heavyweights like Barrick Gold, explorers can be worthwhile as leverage to the gold price. One such explorer is Desert Gold. The share of the Canadian company reacted yesterday with a price jump of over 10% to a project update. In contrast, the outlook for "concrete gold" remains challenging. Vonovia, for example, was once again downgraded by analysts despite the significant share price losses of recent months. At the same time, there are also positive comments.
Read